Comparison of PRF and Corticosteroids in Impacted Third Molar Surgery
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorFinal International University
About this trial
This prospective, randomized interventional study aims to compare the postoperative effects of standard treatment (control), platelet-rich fibrin (PRF), and PRF combined with corticosteroid treatment in patients undergoing impacted mandibular third molar surgery. A total of 60 participants will be randomly assigned to one of three treatment groups according to the study protocol. Postoperative pain, facial swelling, and trismus will be evaluated on postoperative days 1, 2, 3, and 7. The findings of this study are expected to provide evidence regarding the effectiveness of PRF alone and PRF combined with corticosteroid treatment in reducing postoperative complications following impacted mandibular third molar surgery.
Eligibility criteria
Qualifiers
Patients aged 18 years and older.
Patients with good general health
Patients with complete clinical and radiographic examination (panoramic radiograph/CBCT if applicable)
Patients willing and able to attend all postoperative follow-up visits
Disqualifiers
Patients with systemic diseases that may impair wound healing (e.g., uncontrolled diabetes, immunodeficiency).
Pregnant or breastfeeding women.
Patients with acute infection, abscess, or pericoronitis at the surgical site.
Patients with a history of allergy or contraindication to corticosteroids, local anesthetics, or prescribed medications.
Trial design
Treatments tested in this trial
- Platelet-rich fibrin (PRF)
- Dexamethasone
- Amoxicillin/Clavulanic Acid
- Paracetamol
- Chlorhexidine
Treatment groups
60 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov